top of page
The Professional Network for Healthcare Experts
Oxford BioDynamics signs first pharmaceutical EpiSwitch Orion agreement with Johnson & Johnson
Oxford BioDynamics has secured its first pharmaceutical-company agreement for the EpiSwitch Orion platform, partnering with Johnson & Johnson on inflammatory bowel disease biomarker discovery.
nuaxia
14 hours ago2 min read
Agilent completes Proscia acquisition for $240 million upfront to expand AI-enabled digital pathology
Agilent Technologies has completed its acquisition of Proscia for $240 million upfront, adding digital-pathology software and AI-enabled diagnostic capabilities to its life sciences and diagnostics business.
nuaxia
14 hours ago2 min read
bottom of page